Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Molecular Cancer Therapeutics|August 19, 2016
ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological MalignanciesMichael J Flynn, Francesca Zammarchi, Peter C Tyrer, et al.Molecular Cancer Therapeutics|August 2, 2018
Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate CancerSong Cho, Francesca Zammarchi, David G Williams, et al.Biorxiv : the Preprint Server for Biology|December 18, 2023
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastomaAmber K Weiner, Alexander B Radaoui, Matthew Tsang, et al.Nature Communications|September 23, 2021
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphomaHuan-Chang Liang, Mariantonia Costanza, Nicole Prutsch, et al.Cancer Cell|October 25, 2024
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastomaAmber K Hamilton, Alexander B Radaoui, Matthew Tsang, et al.Cell Reports. Medicine|March 27, 2025
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilitiesDanilo Fiore, Luca Vincenzo Cappelli, Liu Zhaoqi, et al.Pageof 3